Trending Industry Today: WUXI APPTEC Leads Losses In Biotechnology Stocks

Moomoo NewsNov 22 02:50 ET

Trending Industry Today: PHARMARON Leads Losses In CRO Stocks

Moomoo NewsNov 22 02:40 ET

Hong Kong stocks fluctuate | CRO concept continues to decline, domestic biomedical investment and financing still at the bottom, overseas business development uncertainty increases.

CRO concept stocks continue to decline. As of the time of writing, wuxi apptec (02359) is down 6.13%, trading at 45.9 Hong Kong dollars; tigermed (03347) is down 5.88%, trading at 32 Hong Kong dollars; pharmaron (03759) is down 5.71%, trading at 13.2 Hong Kong dollars.

Zhitong FinanceNov 22 01:52 ET

Genscript bio (01548) issued 4.18 million shares due to options exercised.

Genscript bio (01548) announced that the company will... on November 18, 2024, according to the 2015...

Zhitong FinanceNov 18 07:47 ET

Genscript Biotech Enters Sub-License Contract for Anti-PD-1 Single Domain Antibodies

MT NewswiresNov 15 03:33 ET

Genscript bio (01548.HK): Nanjing Pengbo has reached a licensing agreement with Lixin Medical Technology Co., Ltd.

Gelonghui November 15th | Genscript Bio (01548.HK) announced that on November 12, 2024, its non-wholly owned subsidiary Nanjing Pongbo Technology Co., Ltd. ("Nanjing Pongbo") entered into a restated and amended license agreement with Lixin Pharmaceutical Technology Co., Ltd. ("Lixin"). Pursuant to the agreement, Nanjing Pongbo agrees to grant Lixin an exclusive global transferable license, with the right to further sublicense, allowing it to develop, produce, commercialize, and

Gelonghui FinanceNov 14 19:32 ET